Skip to content

The “R-3D-2” pilot study - the impact of rehearsal strategies prior rectal cancer surgery, using patient individualised 3D models

The “R-3D-2” pilot study - randomised controlled trial on the impact of surgical rehearsal strategies in rectal cancer surgery using 3d models by using 2 methods

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN75603704
Enrollment
63
Registered
2015-07-12
Start date
2015-05-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer Cancer

Interventions

Surgeons operating on patients randomised to group 1 will undergo Structured Mental Rehearsal (SMR) using patient specific 3D Virtual models. Surgeons operating on patients randomised to group 2 will

Sponsors

University of Leeds
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients due to undergo minimally invasive surgery for rectal cancer surgery 2. They have to be older than 18 years of age 3. Both genders 4. All operations must be performed or supervised by surgeons who performed similar operations > 50 times in the past

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 20/03/2017: 1. Patients planned for a primary Hartmann’s resection (no anastomosis planned) 2. Patients planned for abdominoperineal resection (APR) 3. Patients with anal cancer and benign lesions 4. Patients who cannot represent their interests and lack the capacity to consent for themselves Previous exclusion criteria: 1. Patients planned for a primary Hartmann’s resection (no anastomosis planned) 2. Patients planned for abdominoperineal resection (APR) 3. Patients planned for primary open surgery, partial mesorectal excision (PME) 4. Patients planned for transrectal surgery, “bottom up” surgery 5. Patients with anal cancer and benign lesions 6. Patients who cannot represent their interests and lack the capacity to consent for themselves

Design outcomes

Primary

MeasureTime frame
Surgical performance assessed by video assessment methods (Competency Assessment Tool and Objective Clinical Human Reliability Assessment (OCHRA)). Surgical performance will be assessed for each real procedure. This will be done by recording the pelvic dissection at the time of surgery through the laparoscopic camera. The recording will be sent to two experts who will rate it independently using two validated scoring systems. This process will be repeated for each procedure.

Secondary

MeasureTime frame
1. Peri-operation complications and time to complete surgery will be recorded at the time of surgery 2. Post-operative complications will be recorded after surgery until the patient is discharged from hospital. The patients will not be followed up after they leave the hospital. 3. Specimen quality (margins of dissected tissue clear/not clear of cancerous cells, number of lymph nodes retrieved). This will be recorded for each patient, once this information becomes available from our pathology laboratory. 4. Transcripts of SMR sessions. Each SMR session will be audio recorded and transcribed for qualitative analysis. This will be done throughout the data collection part of the study. 5. Semi-structured interviews. Conducting these interviews aims to explore the overall opinion of surgeons about the SMR process and the patient specific models. These will be conducted after the end of the data collection process.

Countries

United Kingdom

Contacts

Public ContactMarina Yiasemidou

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026